Home > NEWS
Molnupiravir FDA Approval Status Molnupiravir (EIDD-2801/MK-4482) is an investigational, orally bioavailable form of a potent ribonucleoside analog in development for the treatment of COVID-19.1.Molnupiravir works as an antiviral agent by inhibiting the replication of the SARS-CoV-2 virus, th.. 2021-10-25 COVID-19 tracker: CureVac sees hope for vaccine despite trial flop; AZ jab highly protective against death in older adults CureVac said its vaccine, only 48% effective in late-stage clinical trials, could still pose a "strong public health value."Two doses of AstraZeneca's vaccine prevent roughly 94% of deaths in older people, according to Public Health England.The w.. 2021-07-02 Getting to know our products 2021 Currently, Senova is focusing on anti-covid drugs materials such asRemdesivir / Favipiravir / Molnupiravir / Baricitinib and related intermediates, feel free to contact our email sales@senovatech.com for more details. Thanks and wish all are fine despite of.. 2021-06-29 2020's party We were having a league construction activity for celebrating that our company has got to a new point. We chose a hot spring hotel, since we were supposed to stay in GuangZhou Province because of COVID-19. We want to show you that our company is such a lovely .. 2021-02-03 The review of Senova at the CPhI exhibition in Shanghai in 2020 We firstly want to send the greatest congratulations for the successful and promising outcomes from CPhl exhibition 2020. We want to say thank you to everyone here, for your effort and confidence you’ve shown on us, given 2020 is already a tough year fo.. 2020-12-29 SENOVA INVITATION LETTER FOR CPhI CHINA 2020 This is an invitation letter for anyone interested in CPhI China.CPhI China 2020 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. CPhI China is your ONE-STOP SHOP pharmaceutical platform in Asia.We hereby sin.. 2020-12-04
FirstPreviouscurrent 1/9 page total 51 records per page 6 Article123NextEnd
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: 510# in Building 8 of North Area, Dayuan Industry Park, Xili, Nanshan District of Shenzhen,China 518055  Tel: +86-0755-8670 3119 QQ: 530953397 Email: info@senovatech.com